The brokerage firm Motilal Oswal had a ‘Buy call on three stocks on March 11. It has picked Sun Pharma after Checkpoint ...

MUMBAI: Financial services giant Motilal Oswal has promoted Varun Mundra to group head of media and innovations, capping the ...

Sun Pharma surges 3% on Checkpoint Therapeutics acquisition; Motilal Oswal maintains 'Buy' with 22% upside potential. Read ...

India Business Excellence Fund IV (via MO Alternate Investment Advisors) and Motilal Oswal Finvest—have acquired over 60% of ...

Motilal Oswal Financial Services has promoted Varun Mundra to group head– media and innovations. Before this, Mundra served as senior vice president of marketing at Motilal Oswal Financial Services.

Nuvama has downgraded IndusInd Bank to "Reduce" citing concerns over internal derivative trades and management changes, while ...

IndusInd Bank’s shares dropped 27% on March 11 after revealing ₹1,530 crore lapses in its derivatives portfolio, potentially ...

Shares of Sun Pharmaceutical Industries rose more than 3 per cent following ICICI Securities' upgrade of the stock to a 'Buy' ...

Concerns over slowing future earnings growth and challenges in transitioning to a new leadership weigh in on the bank and its ...

It said "In FY24, industry volumes grew by 12 per cent YoY to around 9.4 million units. We expect a 19 per cent CAGR in industry volume over FY24-27, with 35- 40 per cent YoY growth expected in FY25".

Inc42 hosted the first Griffin Retreat, an exclusive gathering of 75 unicorn and soonicorn founders at The Oberoi Amarvilas, ...

As Holi 2025 approaches, investors are looking for vibrant opportunities in the stock market to add long-term wealth to their ...